Health-care companies rose amid mixed earnings.

Moderna shares rose after the maker of RNA vaccines logged quarterly revenue ahead of the Wall Street peg.

French drug giant Sanofi's abrupt move to replace Chief Executive Paul Hudson with German rival Merck KGaA's head Belen Garijo exacerbates near-term uncertainty for the company, warned analysts at brokerage Citi.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

02-13-26 1740ET